Can Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?: Case Series

Can Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?: Case Series

Unresectable cholangiocarcinoma is poorly responded to chemotherapy, especially for the case refractory to gemcitabine and cisplatin. Here, we tested whether high expression of thymidine phosphorylase (TP) can be a predictive biomarker for the indicator for gemcitabine and doxifluridine combination...

Full description

Bibliographic Details
Main Authors:	Kang, Myoung Hee, Lee, Won Sup, Go, Se-Il, Kim, Moon Jin, Lee, Un Seok, Choi, Hye Jung, Kim, Dong Chul, Lee, Jeong-Hee, Kim, Hoon-Gu, Bae, Kyung Soo, Cho, Jae Min
Format:	Online
Language:	English
Published:	Wolters Kluwer Health 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603134/

Similar Items

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
by: Kang, Y-K, et al.
Published: (2013)

Expression of Thymidine Phosphorylase in Lymph Nodes Involved with Mycosis Fungoides and Sézary Syndrome
by: Nie, Xingcao, et al.
Published: (2011)

Research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
by: Ye, Dian-Jun, et al.
Published: (2013)

Erratum to research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
by: Ye, Dian-Jun, et al.
Published: (2013)

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
by: Lindskog, Elinor B., et al.
Published: (2012)

Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
by: Boschetti, Elisa, et al.
Published: (2014)

Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer
by: Lindskog, Elinor Bexe, et al.
Published: (2014)

Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome
by: Bakker, Jaap A., et al.
Published: (2010)

Possible role of thymidine phosphorylase in gynecological tumors as an individualized treatment strategy
by: Shida, Masako, et al.
Published: (2016)

Correction: Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
Published: (2014)

4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
by: Tamura, Ryosuke, et al.
Published: (2014)

D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy
by: Go, Se-Il, et al.
Published: (2015)

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
by: Lim, Jae Yun, et al.
Published: (2015)

Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma
by: WANG, JIANFENG, et al.
Published: (2016)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
by: Noh, Sang Jae, et al.
Published: (2012)

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
by: Soong, R., et al.
Published: (2008)

Thymidine phosphorylase mRNA expression may be a predictor of response to post-operative adjuvant chemotherapy with S-1 in patients with stage III colorectal cancer
by: OGAWA, MASAICHI, et al.
Published: (2014)

Cyclosporine A treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: a case with long-term follow-up
by: Go, Se-Il, et al.
Published: (2012)

Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
by: Moon, Do Chang, et al.
Published: (2016)

Clinicopathologic Study on Combined Hepatocellular Carcinoma and Cholangiocarcinoma: with Emphasis on the Intermediate Cell Morphology
by: Park, Ho Sung, et al.
Published: (2011)

Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
by: Leek, R. D., et al.
Published: (1998)

Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel
by: Bartsch, Rupert, et al.
Published: (2007)

Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.
by: Heldin, N. E., et al.
Published: (1993)

Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
by: Griffiths, L., et al.
Published: (1997)

Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors
by: Bijnsdorp, I V, et al.
Published: (2011)

Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.
by: Maeda, K., et al.
Published: (1996)

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.
by: Fox, S. B., et al.
Published: (1996)

The Sp1 transcription factor is essential for the expression of gliostatin/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes
by: Ikuta, Kenji, et al.
Published: (2012)

Interferon-α Enhances 5′-Deoxy-5-Fluorouridine-Induced Apoptosis by ERK-Dependant Upregulation of Thymidine Phosphorylase
by: Zhu, Yike, et al.
Published: (2013)

A possible role of thymidine phosphorylase expression and5-fluorouracil increased sensitivity in oropharyngeal cancer patients
by: Ranieri, G, et al.
Published: (2007)

Regulation and Novel Action of Thymidine Phosphorylase in Non-Small Cell Lung Cancer: Crosstalk with Nrf2 and HO-1
by: Tertil, Magdalena, et al.
Published: (2014)

Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection
by: Huang, Liu, et al.
Published: (2016)

Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer
by: KIMURA, YUTAKA, et al.
Published: (2016)

Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells
by: Tabata, Sho, et al.
Published: (2014)

Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines
by: Huang, Liu, et al.
Published: (2014)

Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression
by: Terranova-Barberio, Manuela, et al.
Published: (2015)

Intrahepatic cholangiocarcinoma arising in Caroli's disease
by: Jang, Min Hye, et al.
Published: (2014)

Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial
by: Li, Hao, et al.
Published: (2016)

Cholangiocarcinoma arising in von Meyenburg complexes
by: Kim, Hee Kyung, et al.
Published: (2011)

Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy
by: Kim, Miso, et al.
Published: (2015)